Anthropic has rapidly expanded its footprint in healthcare this year, rolling out a HIPAA-compliant AI platform for providers, investing in drug discovery and public health initiatives, advancing cybersecurity programs aimed at protecting critical infrastructure and weighing in on the future of AI regulation.
Here are eight of the company’s biggest healthcare moves so far in 2026, as reported by Becker’s:
- The American Hospital Association, American Medical Association, Anthropic and Elevance Health are part of a national workgroup developing recommendations for how state medical boards should regulate AI in clinical practice. Led by the Federation of State Medical Boards, the group is focused on AI systems that perform clinical functions with limited or no physician supervision, including emerging uses in diagnosis and prescribing. The group met in Washington in early October, and draft recommendations are expected in the coming weeks or months, FSMB confirmed to Becker’s.
- Anthropic is expanding access to its most advanced cybersecurity AI models, including Claude Mythos 5.1, to regional hospitals and other critical infrastructure operators. The expanded Cyber Verification Program replaces Project Glasswing’s limited-access approach with three tiers covering defensive cybersecurity, penetration testing and specialized security research. Epic, an existing Glasswing participant, will retain access. Anthropic said Glasswing partners identified at least 129,000 verified software vulnerabilities from April to July, including more than 33,000 rated critical or high severity. The expansion gives more hospitals an opportunity to use advanced AI tools to identify and address cybersecurity weaknesses.
- At June 30 event in San Francisco, Eric Kauderer-Abrams, Anthropic’s life sciences head, said Anthropic is launching an internal drug discovery program with a focus on neglected diseases that traditional pharmaceutical companies would not consider commercially attractive.
- On June 10, Anthropic published two policy frameworks calling for stronger federal oversight of advanced AI systems, including mandatory safety testing, independent evaluations and penalties for companies that violate safety requirements. The company highlighted cybersecurity threats to critical infrastructure, including hospitals, as a key risk area and urged investments in more secure software and modernization of legacy systems. Anthropic also opposed federal preemption of state AI laws unless national regulations meet or exceed the standards outlined in its proposals.
- On June 9, Anthropic launched Claude Fable 5 and Claude Mythos 5, a new class of AI models the company says accelerated parts of its internal drug design work by about 10 times. Anthropic reported the models demonstrated advanced capabilities in drug discovery, protein engineering and genomics, including generating novel scientific hypotheses and autonomously completing complex biology research tasks. While Fable 5 is available broadly, the more powerful Mythos 5 is currently limited to select partners and researchers.
- On June 2, Anthropic expanded Project Glasswing, adding 150 organizations to its initiative aimed at identifying and remediating critical software vulnerabilities using its unreleased Claude Mythos Preview model. The company said initial participants uncovered more than 10,000 high- and critical-severity flaws, prompting the program’s expansion into sectors including healthcare, energy and communications. Anthropic also signaled plans to broaden access to its cybersecurity tools while continuing to develop safeguards designed to prevent misuse of the model’s advanced cyber capabilities.
- In May, Anthropic committed $200 million in grants and Claude-related support to the Gates Foundation, with a focus on advancing healthcare initiatives. The partnership will dedicate resources to accelerating drug and vaccine development and helping governments make better use of health data, particularly in low- and middle-income countries.
- On Jan. 11, Anthropic launched Claude for Healthcare, a HIPAA-compliant version of its AI platform tailored for providers, payers, life sciences organizations and patients. The platform includes tools for prior authorizations, claims appeals, care coordination, regulatory submissions and patient support, while integrating with healthcare data sources such as CMS coverage databases, ICD-10 codes and provider registries. Anthropic also expanded its life sciences offerings to support clinical trial operations and regulatory workflows.
Editor’s note: This article was updated Oct. 16.
The post Anthropic’s biggest healthcare bets: 8 key moves appeared first on Becker's Hospital Review | Healthcare News & Analysis.